Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23455,85,1.19 [0.97-1.46],0.1023785666607259
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23950,126,0.97 [0.82-1.14],0.6974212660197323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23742,872,1.06 [0.99-1.12],0.0913387306398743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Candidiasis,23974,255,1.01 [0.90-1.14],0.8099378736772216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23291,2374,1.04 [1.00-1.08],0.0403426253478841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23515,1797,1.03 [0.99-1.08],0.1872687858983533
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23802,863,1.03 [0.96-1.09],0.403739395272691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23908,37,0.90 [0.67-1.21],0.4837691181265976
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22874,556,1.03 [0.95-1.12],0.4389663028316192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22102,528,1.05 [0.97-1.13],0.2727044032779571
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22317,146,1.01 [0.87-1.18],0.878220464735446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17806,1046,1.08 [1.02-1.15],0.0085637300762124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22122,249,1.07 [0.95-1.21],0.2400220729318211
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23942,1003,1.01 [0.96-1.07],0.680529121476467
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,24031,312,1.00 [0.90-1.11],0.9815160469942568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23399,529,1.07 [0.98-1.16],0.1144676370067523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23980,610,1.05 [0.97-1.13],0.2401484813564003
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23067,128,0.96 [0.81-1.13],0.6005815170338002
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24074,26,1.18 [0.81-1.72],0.3901953114021294
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23907,537,1.02 [0.94-1.10],0.6681646258965984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23934,63,1.02 [0.81-1.29],0.8512971698330554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23986,151,1.12 [0.96-1.31],0.1375002171366852
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23971,136,1.12 [0.95-1.31],0.1853247842459838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23168,298,1.11 [1.00-1.24],0.0549035681687917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23075,205,1.04 [0.92-1.19],0.5050077052532749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23003,64,0.98 [0.78-1.23],0.8829081585178766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24049,46,1.03 [0.78-1.34],0.8498447080583678
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24019,115,0.95 [0.80-1.13],0.5781088936112524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral warts,23943,39,0.83 [0.62-1.10],0.1913306501244323
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23949,45,1.01 [0.77-1.33],0.94159503028875
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,23815,276,1.18 [1.05-1.32],0.0045456904864375
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23996,64,1.17 [0.92-1.48],0.1958619173784011
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23972,68,1.33 [1.05-1.68],0.0173214653926842
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10735,35,1.26 [0.91-1.74],0.1621743303736654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23894,1014,1.02 [0.96-1.08],0.4769643707873999
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of meninges,24062,41,1.04 [0.78-1.38],0.8106086126693686
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24044,44,0.89 [0.68-1.16],0.3892405049521554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24052,79,1.11 [0.90-1.36],0.337645506486552
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of ovary,13282,84,1.00 [0.82-1.22],0.9837597099472516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Ascending colon,24066,237,0.95 [0.84-1.07],0.3804147710780022
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Caecum,24063,178,1.04 [0.90-1.19],0.6038336665784452
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24007,47,1.08 [0.83-1.42],0.5580779714503799
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Descending colon,24069,153,0.94 [0.81-1.09],0.4035995927414049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,24035,249,0.99 [0.88-1.11],0.8621439106723532
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24003,479,1.02 [0.93-1.11],0.6902689489462595
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Transverse colon,24066,266,0.99 [0.88-1.10],0.7941308297513625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Carcinoma in situ of breast,11384,76,0.82 [0.67-1.00],0.0541703791390957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11422,85,0.91 [0.75-1.10],0.3342259721933593
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20765,30,0.95 [0.68-1.32],0.7526903813155712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20770,35,1.03 [0.76-1.40],0.8499616522701319
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24036,94,0.96 [0.80-1.16],0.7040537134008358
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",24036,92,0.96 [0.80-1.17],0.7071873763720056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,12715,355,0.96 [0.87-1.06],0.4055847360160309
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lung cancer and mesothelioma,17830,160,1.10 [0.95-1.28],0.2127495768254624
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lymphoid leukaemia,20762,27,0.89 [0.63-1.25],0.4950176150199097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20861,126,1.04 [0.88-1.22],0.6523454343726577
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20813,78,1.06 [0.86-1.31],0.5782780872304016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11469,67,0.93 [0.75-1.16],0.5267267607027317
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20778,43,0.78 [0.60-1.01],0.0627737822794608
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20789,54,1.12 [0.87-1.45],0.3789192840236703
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20800,65,1.08 [0.85-1.35],0.5370543836255882
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11450,48,1.18 [0.90-1.56],0.2310893515752689
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20786,51,1.11 [0.86-1.44],0.4224216030419924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9673,340,1.03 [0.93-1.14],0.5297625864757647
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20816,81,1.09 [0.89-1.34],0.4089096803906087
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20783,48,1.19 [0.90-1.56],0.2146654322058192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20790,55,0.86 [0.68-1.09],0.2093454835948208
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,23868,188,1.01 [0.89-1.16],0.8313828526333006
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of trunk,24032,86,0.96 [0.78-1.17],0.6594148058859444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanoma in situ,20746,40,1.31 [0.97-1.78],0.0828067758397913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20791,56,1.09 [0.85-1.40],0.4927284374525463
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20839,104,1.07 [0.89-1.28],0.4731487321529271
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20842,107,1.12 [0.93-1.34],0.2219014648004842
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20794,59,1.06 [0.83-1.35],0.620549173308427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,23914,129,1.04 [0.89-1.23],0.6232719347555765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21298,563,0.99 [0.92-1.07],0.8791822225927065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21327,592,0.99 [0.92-1.07],0.8749971320634825
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23829,256,1.02 [0.91-1.15],0.6930685767406473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22840,41,1.27 [0.94-1.71],0.1244215602953145
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23638,65,1.09 [0.87-1.37],0.4646604690185455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23373,1937,1.06 [1.02-1.11],0.0068093359785024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23051,19,1.01 [0.67-1.53],0.9530016360685012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23762,29,1.36 [0.95-1.96],0.0939137232981107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23683,884,1.05 [0.99-1.12],0.0992628400726124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23683,884,1.05 [0.99-1.12],0.0992628400726124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22848,49,1.05 [0.80-1.36],0.7271663502552592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23827,795,1.09 [1.02-1.17],0.0092222947123025
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23827,94,1.02 [0.84-1.24],0.8315158384107204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23618,45,0.98 [0.74-1.29],0.8889045720602633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23611,38,1.24 [0.91-1.69],0.1808924327338284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23906,173,0.92 [0.80-1.05],0.2161750409721504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24004,60,1.28 [1.00-1.64],0.0537887251309446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23882,149,0.83 [0.72-0.96],0.0122288456217276
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23096,64,1.01 [0.81-1.27],0.8998339775497728
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20659,177,0.99 [0.87-1.14],0.9320627072813448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22377,106,1.05 [0.88-1.26],0.5867508262447031
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22398,127,1.04 [0.89-1.23],0.6170393069767297
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20515,33,1.49 [1.05-2.11],0.0267123860643945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22336,64,0.90 [0.72-1.12],0.3307989085482146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22014,124,0.93 [0.79-1.09],0.3446563473862853
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23945,144,1.01 [0.87-1.17],0.9150542935082496
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23848,47,0.84 [0.65-1.09],0.180981156428775
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23833,32,1.21 [0.86-1.69],0.2694363656529103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23718,1446,1.03 [0.98-1.08],0.235337775834714
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21545,1405,1.03 [0.98-1.08],0.2837163060998028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20519,37,1.17 [0.85-1.60],0.3374412091659756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22635,52,0.94 [0.73-1.20],0.6047415726539762
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20643,161,1.25 [1.07-1.46],0.0039487819599879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20537,55,1.13 [0.88-1.46],0.3388304156469188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22566,2084,1.11 [1.07-1.16],2.6705664476839786e-07
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20587,105,1.02 [0.85-1.22],0.8433377472993229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20824,342,1.13 [1.02-1.25],0.0213443003799754
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23988,228,1.17 [1.03-1.33],0.0132648812194603
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23851,91,1.42 [1.15-1.74],0.0008783894712293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20571,89,1.11 [0.91-1.35],0.3162345028286508
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20517,35,0.93 [0.69-1.27],0.6531662209189681
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23700,1117,1.10 [1.04-1.16],0.0007419358558266
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20595,113,1.06 [0.89-1.27],0.5022571374497291
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20616,134,0.97 [0.83-1.13],0.6689073302506738
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20820,338,1.09 [0.98-1.20],0.1066109556174386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20537,55,1.03 [0.80-1.32],0.8334299005611269
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23846,86,1.41 [1.14-1.75],0.0013628271641193
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20748,266,1.04 [0.93-1.17],0.4797509851488971
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20751,269,1.07 [0.96-1.20],0.233274505518572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21943,53,1.14 [0.88-1.47],0.3307679957721086
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23465,2983,1.09 [1.05-1.12],1.870985130554164e-06
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22610,27,1.03 [0.72-1.47],0.878588174860097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22635,52,1.03 [0.80-1.33],0.8273861568121682
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23913,1705,1.00 [0.96-1.04],0.9468962847044968
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23915,1701,1.00 [0.95-1.04],0.9033028443876848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22615,32,1.36 [0.97-1.92],0.0778791237231554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23796,1087,1.05 [0.99-1.11],0.0800509676408474
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21268,786,1.06 [0.99-1.13],0.0941897790276095
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24065,112,0.87 [0.73-1.03],0.0957481047809162
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23831,30,0.87 [0.63-1.20],0.4053411401850683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22787,78,0.99 [0.80-1.21],0.897934577454869
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22806,97,1.15 [0.95-1.39],0.1651293792341669
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20593,111,1.35 [1.12-1.63],0.001436204053753
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22499,107,1.16 [0.96-1.39],0.1201196863331535
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1502,60,0.91 [0.73-1.13],0.3864347150078937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1596,165,1.03 [0.89-1.18],0.7241627659034819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22429,37,1.22 [0.90-1.66],0.2033522708061907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1474,32,1.01 [0.74-1.38],0.9430073117124282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23716,1324,1.09 [1.03-1.14],0.0016568301213458
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23861,60,1.00 [0.79-1.26],0.973397182517204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22131,241,1.01 [0.89-1.13],0.912761540640124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20840,358,1.04 [0.94-1.15],0.4228978962582953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23995,152,0.96 [0.83-1.11],0.5646930193437465
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23410,47,0.95 [0.73-1.24],0.7069252552771692
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,22970,695,1.03 [0.96-1.10],0.4750119454502254
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Aortic aneurysm,23456,93,1.04 [0.86-1.26],0.6927392504415073
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23391,28,1.39 [0.96-2.01],0.0829245386457953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23458,95,1.10 [0.90-1.33],0.3521890855831321
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17109,810,1.01 [0.95-1.08],0.6628078913481797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,AV-block,21895,159,1.00 [0.87-1.16],0.9695349188532498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24045,228,0.88 [0.78-0.99],0.0356865598308433
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiac arrest,16393,94,0.98 [0.81-1.18],0.8068827859552149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,21853,117,0.94 [0.79-1.11],0.4604939833864517
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21809,73,0.90 [0.73-1.11],0.3069839943806966
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24076,15,0.62 [0.40-0.95],0.0293847112926509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,22206,470,1.02 [0.94-1.11],0.6734094582873285
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23434,1168,1.08 [1.02-1.14],0.0044248096240451
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22362,5292,1.04 [1.02-1.07],0.0009689902784908
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,23073,160,0.96 [0.83-1.10],0.530853162345913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Endocarditis,21777,41,0.85 [0.64-1.12],0.2473322755160673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23968,456,1.08 [0.99-1.18],0.0784135441167167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,22854,4304,1.05 [1.02-1.08],0.000450801098972
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",22863,4313,1.05 [1.02-1.08],0.0005196720884078
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, portal",23919,50,0.82 [0.64-1.05],0.1233889922428408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18631,81,0.93 [0.76-1.13],0.4766300747812575
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18591,41,0.92 [0.70-1.22],0.5677577756585797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,23986,600,0.99 [0.92-1.07],0.7875733836006532
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23614,58,1.13 [0.89-1.45],0.3221205450924312
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23580,1305,1.07 [1.01-1.12],0.0153939323304204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23881,274,1.07 [0.96-1.20],0.2396636198579373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Left bundle-branch block,21919,183,1.08 [0.94-1.24],0.281771973525669
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23852,525,1.07 [0.99-1.16],0.0912477135488287
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22704,429,1.08 [0.98-1.18],0.1116216267618859
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24026,106,1.01 [0.84-1.20],0.9317100496573978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24061,183,1.13 [0.99-1.30],0.0769701751560725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Oesophageal varices,22944,31,0.73 [0.54-0.99],0.041290892845833
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other aneurysm,23404,41,0.86 [0.65-1.14],0.2937130085844619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,21960,224,1.01 [0.89-1.14],0.8602031993883074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23422,59,1.27 [0.99-1.63],0.0582765589817818
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23489,126,0.98 [0.83-1.15],0.7849626140593675
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21849,113,0.89 [0.76-1.06],0.1956123268312445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other disorders of veins,22976,63,0.81 [0.65-1.01],0.0569256053941365
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22958,45,1.09 [0.82-1.44],0.551673741788012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23394,33,0.85 [0.63-1.16],0.315607414550621
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22995,82,0.96 [0.78-1.17],0.6606219015719639
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22253,517,1.03 [0.95-1.12],0.4927241777460138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23428,42,0.83 [0.63-1.09],0.1767411635113083
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23674,311,1.06 [0.95-1.18],0.2890277277105393
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23681,139,0.99 [0.85-1.16],0.9147882063812768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23569,208,1.00 [0.88-1.14],0.9509360879302204
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16514,215,0.97 [0.86-1.10],0.6431883711291966
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23526,185,1.08 [0.94-1.23],0.2841245825583854
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23130,217,1.04 [0.92-1.18],0.4937247870234084
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23834,292,1.08 [0.97-1.21],0.1462952165261748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24038,277,1.05 [0.94-1.18],0.3746829741474539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Right bundle-branch block,21887,151,0.97 [0.84-1.13],0.7132504685487384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23678,136,1.00 [0.86-1.17],0.9933524081546788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23465,104,0.99 [0.82-1.18],0.8830313922722631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23876,320,1.07 [0.96-1.19],0.2051352520151903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23853,353,1.04 [0.94-1.15],0.4166609725403539
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23591,49,0.96 [0.74-1.25],0.762365489097058
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23412,50,0.95 [0.73-1.23],0.6967732896373164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23722,115,1.12 [0.94-1.33],0.2102981096710663
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23480,153,1.11 [0.95-1.28],0.1938634076945712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,23178,265,0.94 [0.84-1.04],0.2354432455322054
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23373,44,1.02 [0.77-1.35],0.8740101670346956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23922,455,1.06 [0.97-1.15],0.2060189471995263
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23939,332,0.98 [0.88-1.08],0.66037881850732
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21429,1245,1.05 [1.00-1.11],0.0594593936040438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,23417,3233,1.03 [1.00-1.06],0.0915407823220333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23886,387,0.99 [0.90-1.09],0.8400490601009794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21659,1475,1.02 [0.97-1.07],0.4085714505469501
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20258,74,1.09 [0.88-1.35],0.4407218368417961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,23595,1343,1.01 [0.96-1.07],0.589334479373837
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21736,1552,1.02 [0.97-1.06],0.5144929878365175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Vascular dementia,23976,18,0.96 [0.63-1.47],0.8522078727419318
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Alzheimer disease,24075,64,0.88 [0.71-1.10],0.2763147249799605
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Bell's palsy,22606,66,0.90 [0.72-1.12],0.3423609970435498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22963,423,1.03 [0.94-1.13],0.5104126243630659
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral cysts,23759,172,0.97 [0.85-1.12],0.7054941597185574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24000,199,0.99 [0.87-1.13],0.9051358531728724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23945,21,0.97 [0.66-1.44],0.8866274989912167
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24064,48,1.12 [0.86-1.47],0.4098781967373258
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23637,50,0.84 [0.66-1.08],0.1844695528999293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,22716,229,0.95 [0.84-1.07],0.3919680188010634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23649,1162,1.03 [0.98-1.09],0.2540290598670381
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24047,164,1.10 [0.95-1.27],0.1951094372870389
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,23636,1452,0.95 [0.91-1.00],0.0565823332122574
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Generalized epilepsy,23751,47,1.07 [0.82-1.40],0.6244749021464032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,23947,146,1.01 [0.87-1.18],0.9050470044818988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hydrocephalus,23630,43,1.21 [0.90-1.61],0.2068006378616671
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24055,60,1.30 [1.02-1.67],0.0365116600410499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22608,68,0.87 [0.70-1.08],0.2067827975817769
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22609,69,1.04 [0.83-1.29],0.7548176356130795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Memory loss,23943,67,0.94 [0.75-1.17],0.5795794584057788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,22853,366,1.10 [1.00-1.22],0.0527350641609186
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23999,331,1.10 [0.99-1.22],0.0777670358022071
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Motor neuron disease,17481,89,1.12 [0.92-1.37],0.2635475306574705
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23889,134,0.98 [0.84-1.15],0.7856379648831211
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23541,1001,1.04 [0.98-1.10],0.2220610195783596
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,22803,2664,1.02 [0.99-1.06],0.2041181888219928
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23991,67,1.11 [0.88-1.40],0.3638162240577486
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22884,344,1.05 [0.95-1.15],0.3821203278053579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24014,203,1.01 [0.89-1.15],0.9011466157314412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20071,282,0.98 [0.88-1.10],0.7729441181231759
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23639,52,0.94 [0.73-1.21],0.6225633649885
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other disorders of nervous system,23691,104,0.98 [0.82-1.17],0.8226336592744439
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23954,71,1.07 [0.86-1.33],0.5489219597704982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other facial nerve disorders,22624,84,0.92 [0.75-1.11],0.3808534624445404
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other headache syndromes,22543,56,1.09 [0.85-1.39],0.5192374489321101
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,23971,384,1.02 [0.93-1.12],0.6611371515904546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,22996,509,1.03 [0.95-1.11],0.5427878157977595
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Parkinson's disease,24062,74,1.11 [0.89-1.38],0.3509917890702755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23642,55,1.06 [0.82-1.36],0.6781876461768346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Restless leg syndrome,24074,32,1.18 [0.84-1.64],0.3438751457099713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,23858,443,1.03 [0.94-1.12],0.5216916530993561
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Small fibre neuropathy,23843,32,1.18 [0.84-1.66],0.338336028570621
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24061,114,1.03 [0.87-1.23],0.7059928633541235
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22567,27,0.93 [0.66-1.32],0.6883489637681504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24075,65,0.90 [0.72-1.13],0.359448599855602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23964,17,0.96 [0.62-1.49],0.8641832453969509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23654,36,0.98 [0.73-1.33],0.911514302104035
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23757,190,0.99 [0.86-1.12],0.826808631801703
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24000,170,1.04 [0.90-1.20],0.5966633801059502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23419,34,0.87 [0.64-1.19],0.3883341653919114
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23449,64,1.14 [0.90-1.45],0.264164067987377
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23991,29,0.87 [0.62-1.22],0.4181388164774851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23904,59,1.02 [0.80-1.29],0.8808171625569486
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1477,35,1.06 [0.79-1.44],0.6861613692554318
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1747,72,0.91 [0.74-1.12],0.388430729632412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23692,74,0.94 [0.76-1.16],0.5745585229338956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23970,546,1.03 [0.95-1.11],0.5120804432067565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23804,419,0.93 [0.85-1.01],0.0990998182035521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23506,121,0.84 [0.71-0.98],0.0269216980126657
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23995,428,1.01 [0.93-1.11],0.7898508112614058
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24068,50,0.89 [0.69-1.14],0.3515180718698264
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23926,359,1.02 [0.92-1.12],0.7356260163659883
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24039,194,0.96 [0.85-1.10],0.5820601243044333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24019,120,0.90 [0.76-1.05],0.188609528680225
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23400,15,1.00 [0.62-1.61],0.9991869732812824
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23411,26,1.21 [0.83-1.76],0.3238819465534105
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23415,30,0.79 [0.58-1.09],0.1535645208254874
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24033,337,1.02 [0.92-1.13],0.7176434979098554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23777,81,0.91 [0.74-1.11],0.342324558870082
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23588,21,1.23 [0.81-1.87],0.3261602924735335
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23907,62,1.07 [0.84-1.35],0.595992745660697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23979,134,0.94 [0.80-1.10],0.4272052424006293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23714,147,1.02 [0.88-1.19],0.7527039014093062
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23969,70,0.90 [0.73-1.12],0.3373079023747456
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23918,222,1.08 [0.96-1.23],0.2029312083470781
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23715,97,1.12 [0.93-1.36],0.2303016464643221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23456,952,1.06 [1.00-1.13],0.0586214634009348
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23957,112,0.96 [0.81-1.14],0.6223107527492582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24054,101,1.02 [0.85-1.23],0.821237002193884
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23619,234,0.95 [0.84-1.07],0.4004177977781912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23880,35,0.97 [0.71-1.32],0.8334996622139954
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24052,34,0.89 [0.66-1.21],0.4683565063187629
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23421,36,0.96 [0.71-1.29],0.7752114045813187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23488,103,0.94 [0.79-1.12],0.4910016386907627
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23481,57,0.93 [0.73-1.18],0.5531118563518846
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23618,51,1.01 [0.78-1.31],0.9391123408819554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23471,47,1.02 [0.78-1.33],0.8973849338536392
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23741,45,1.11 [0.84-1.47],0.4586399967861192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23776,80,0.87 [0.71-1.06],0.1653963773563513
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23460,75,1.04 [0.84-1.28],0.7263342102830657
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23532,108,1.25 [1.04-1.51],0.0171136766325965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23453,29,1.02 [0.72-1.45],0.9034509617326786
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23229,725,1.03 [0.96-1.10],0.4622223511754911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23428,43,0.82 [0.63-1.07],0.135982084387143
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23889,271,1.05 [0.94-1.17],0.3976491192842784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23650,32,0.91 [0.66-1.25],0.5447843173880733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23725,107,0.99 [0.83-1.18],0.9041614812758382
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23895,55,0.88 [0.70-1.12],0.309886173103391
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24035,82,1.00 [0.82-1.22],0.9973160699765198
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23964,124,0.97 [0.82-1.14],0.6912605000855165
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23891,51,0.97 [0.75-1.24],0.7868184550400192
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23889,49,1.10 [0.84-1.43],0.5018518281880837
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23993,477,1.02 [0.93-1.11],0.702429162733689
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23810,294,1.03 [0.93-1.15],0.5677637841604926
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23602,86,1.00 [0.82-1.22],0.9956723033231524
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23585,69,1.12 [0.89-1.40],0.3246588079367399
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute pharyngitis,23815,67,0.85 [0.69-1.06],0.1574110371793798
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23957,209,0.96 [0.84-1.09],0.494426565940161
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23803,55,0.89 [0.70-1.14],0.3640373744129034
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza,22925,70,0.95 [0.77-1.18],0.6399379744375208
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22924,69,0.96 [0.77-1.20],0.7341840795786081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic asthma (mode),17785,115,1.03 [0.86-1.22],0.7691358484618459
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic rhinitis,23955,279,1.10 [0.98-1.23],0.1112139452918516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19089,1550,1.03 [0.98-1.08],0.2285855316371232
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19190,1520,1.04 [0.99-1.09],0.154833533601466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23823,88,1.05 [0.86-1.28],0.6314499397786881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22907,52,1.23 [0.94-1.61],0.1265519349302951
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bronchiectasis,21390,153,1.09 [0.94-1.27],0.2472073809731959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21272,35,1.13 [0.82-1.56],0.4590341392418886
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23303,2066,1.03 [0.99-1.07],0.1680565897535178
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22775,60,1.07 [0.84-1.37],0.56741807777851
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,22859,144,1.23 [1.05-1.44],0.0112442175655926
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23984,636,1.00 [0.93-1.07],0.9839485273517804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,22832,117,1.05 [0.89-1.25],0.5747585386434315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22380,3731,1.04 [1.01-1.08],0.0056882475204249
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23049,334,1.03 [0.93-1.14],0.5968226353730423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,23802,454,0.99 [0.91-1.08],0.9054920318483348
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Emphysema,21402,165,1.15 [1.00-1.34],0.0571371893772385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22951,99,0.97 [0.81-1.17],0.7705107228227812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23912,1057,1.02 [0.97-1.08],0.4296932215889114
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,22973,121,1.01 [0.85-1.19],0.9363647456628738
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Later onset COPD,22787,182,1.02 [0.89-1.16],0.8285901984226867
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24070,134,0.96 [0.82-1.12],0.580331072746098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,22821,106,1.10 [0.92-1.32],0.3021820892931933
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23883,559,1.08 [1.00-1.17],0.0464594362278233
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,23921,1102,1.08 [1.02-1.14],0.0065185259418566
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23502,787,1.08 [1.01-1.16],0.0213129504795168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other pleural conditions,22851,32,1.09 [0.78-1.52],0.6108510029307281
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24019,179,0.93 [0.81-1.07],0.2989603799697472
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24006,751,1.10 [1.03-1.18],0.0073999699099477
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,23347,528,1.06 [0.98-1.15],0.1285155364635969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural plaque,22868,49,1.06 [0.81-1.38],0.684910153400326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23727,872,1.02 [0.95-1.08],0.6259499311024636
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24052,116,0.99 [0.83-1.17],0.883340095388898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumothorax,22876,57,1.31 [1.01-1.69],0.0397124784285907
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pollen allergy,24049,242,1.09 [0.97-1.23],0.1540159853551594
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pulmonary oedema,23876,36,0.78 [0.59-1.04],0.0932248329016372
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Respiratory insufficiency,17701,31,1.12 [0.79-1.57],0.5233740560350049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23863,539,1.08 [0.99-1.17],0.0691317874583634
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22994,279,1.10 [0.98-1.23],0.0990138485550546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Viral pneumonia,23020,165,1.01 [0.87-1.16],0.914740577812072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23840,141,1.00 [0.86-1.17],0.9991553334241076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13844,86,0.94 [0.77-1.15],0.5421800751714339
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18402,54,0.97 [0.76-1.24],0.8191622184573795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,23899,132,0.89 [0.76-1.04],0.147580854646757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute gastritis,19218,58,0.91 [0.72-1.15],0.4461813648285588
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,22656,148,1.01 [0.87-1.17],0.8934258162140903
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute peritonitis,23671,60,1.09 [0.86-1.39],0.4623280131289081
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Alcoholic liver disease,23396,77,0.89 [0.72-1.09],0.2487295525140654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Barrett oesophagus,19476,316,1.04 [0.94-1.15],0.4605310349125804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22559,51,1.02 [0.79-1.32],0.8602556323503467
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23720,51,1.02 [0.79-1.32],0.8602838918244815
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,22665,157,1.01 [0.88-1.17],0.8665405090037874
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,23335,827,1.03 [0.96-1.10],0.3997546557299352
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,19380,220,1.08 [0.95-1.23],0.2318172598164276
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic pancreatitis,22546,38,0.84 [0.63-1.12],0.2319501836470895
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23945,76,0.80 [0.66-0.98],0.0270531866690207
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,22829,100,1.14 [0.94-1.37],0.1809254259501494
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Collagenous colitis,22701,49,1.15 [0.88-1.51],0.3060404102834956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23908,180,0.93 [0.81-1.06],0.279015832193113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,23883,1019,1.03 [0.97-1.09],0.3416818189474428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,22736,84,1.00 [0.82-1.22],0.9768373326659592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23770,56,0.98 [0.77-1.25],0.8740073587256595
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22730,78,0.99 [0.81-1.22],0.955074471541427
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,23341,226,1.05 [0.93-1.19],0.4187246042582998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22226,1574,1.02 [0.97-1.07],0.4031817971162297
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,23936,169,0.96 [0.83-1.10],0.5635143902406609
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,23971,652,1.01 [0.94-1.09],0.7006085490305001
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22538,3378,1.01 [0.98-1.04],0.5884425491994156
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23649,534,1.06 [0.98-1.15],0.1733183422067275
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,24004,393,1.11 [1.01-1.22],0.0317510246406943
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23232,117,1.15 [0.96-1.37],0.1256548180324798
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of salivary glands,23093,61,1.19 [0.93-1.52],0.1611139947622264
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23830,1101,1.06 [1.01-1.13],0.0292966367802046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of tongue,23095,106,1.02 [0.85-1.22],0.8325148600830287
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23625,1117,1.01 [0.96-1.07],0.6425633259157392
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20487,2139,1.05 [1.01-1.09],0.0268659610934153
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,19287,127,0.99 [0.84-1.17],0.926105824722553
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24010,99,0.94 [0.78-1.13],0.5083273151155836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23960,72,1.26 [1.00-1.58],0.0491610614292695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23413,94,0.89 [0.74-1.06],0.1955030404783374
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18504,156,0.92 [0.80-1.06],0.2438660302000226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,19614,454,1.01 [0.92-1.10],0.8501444108641854
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,19414,254,0.93 [0.83-1.04],0.1935133228084788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21131,1971,1.02 [0.98-1.06],0.3369568091725027
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19526,366,0.96 [0.87-1.05],0.3791431836025922
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19580,6972,1.02 [1.00-1.04],0.0652886221199074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,23608,879,1.03 [0.97-1.10],0.3121742210822531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23175,60,1.15 [0.89-1.47],0.2830475521588507
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19144,1112,1.08 [1.02-1.14],0.0080245164361072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23365,46,1.05 [0.80-1.38],0.7227146714143484
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,23031,2379,1.02 [0.99-1.06],0.2200067477672161
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,23970,67,1.36 [1.07-1.73],0.0117169572141278
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impaction of intestines,18380,32,1.41 [1.00-2.00],0.0530587083919422
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,21249,597,1.04 [0.97-1.12],0.2789366434773065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20723,71,0.93 [0.75-1.15],0.4824238144333862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18412,64,0.90 [0.72-1.13],0.3707894996311661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22850,121,1.22 [1.02-1.45],0.0252980334854448
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18854,506,1.08 [0.99-1.17],0.085787277782909
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24050,342,1.12 [1.01-1.24],0.0299222619515303
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23263,611,1.09 [1.01-1.18],0.0230151220214767
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23421,769,1.11 [1.03-1.18],0.0033687560969313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,19281,121,1.26 [1.06-1.50],0.0089098270955056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,19585,425,1.06 [0.97-1.16],0.1938268470731689
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24035,116,1.01 [0.85-1.21],0.8663041723044955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20695,43,1.30 [0.97-1.75],0.0808373361440746
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19483,1135,1.02 [0.96-1.07],0.5628666320184572
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22680,172,0.97 [0.85-1.12],0.7138609135332978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22649,141,0.96 [0.83-1.12],0.622580776522548
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,19680,1332,1.02 [0.97-1.07],0.4794250225016038
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,22615,4267,1.02 [0.99-1.05],0.1670229061523376
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23093,169,1.02 [0.89-1.18],0.7722518655823857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,23844,525,1.02 [0.94-1.10],0.6783610444020898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19640,480,1.02 [0.94-1.11],0.6658914469470404
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of pancreas,22580,72,1.01 [0.82-1.26],0.8985361252867186
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23956,345,1.11 [1.01-1.23],0.0396671710450406
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19833,673,1.00 [0.94-1.08],0.9053222447866768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23622,893,1.04 [0.97-1.10],0.2496216855984603
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23266,151,1.01 [0.87-1.18],0.8794278965141559
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19411,1063,1.04 [0.98-1.10],0.2220008853074092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20701,1541,0.98 [0.94-1.03],0.4509940194995125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23391,72,0.82 [0.67-1.01],0.0671858630407543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23321,669,1.09 [1.01-1.17],0.0254255535655206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18560,212,1.08 [0.95-1.23],0.2393374983735554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23945,85,1.18 [0.96-1.46],0.1096876769480536
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18660,312,1.02 [0.92-1.14],0.6426859195122405
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22852,123,1.15 [0.97-1.37],0.1079061393138537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Recurring oral aphthae,24065,53,1.05 [0.81-1.36],0.7029235404986546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23126,109,1.07 [0.90-1.28],0.4381481237298305
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Toxic colitis,22674,22,0.79 [0.54-1.15],0.2209707943127659
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19328,168,1.10 [0.95-1.27],0.1851098321130249
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,22782,130,1.29 [1.09-1.52],0.0035323992261181
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22765,113,1.23 [1.02-1.47],0.0259411815897371
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,20889,237,0.95 [0.85-1.07],0.4289587367771
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18439,91,1.16 [0.95-1.41],0.1506591185098998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,20857,205,1.07 [0.94-1.22],0.2807029928940012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Volvulus,18406,58,1.01 [0.79-1.28],0.9621548479660472
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24035,135,0.97 [0.83-1.13],0.6977533353742804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23842,73,0.90 [0.73-1.10],0.2987895127123129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22771,127,1.00 [0.85-1.18],0.9677572952844724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23512,489,0.98 [0.90-1.06],0.597817498040843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23200,177,1.06 [0.92-1.22],0.3982357767034801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22795,151,0.97 [0.83-1.13],0.6783332203916972
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23844,202,1.11 [0.97-1.27],0.1136481460976282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23985,343,1.07 [0.97-1.18],0.1849357363865208
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23682,40,1.22 [0.90-1.64],0.2048681482499566
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22785,2249,1.02 [0.98-1.06],0.3071425452201262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23672,375,0.94 [0.86-1.03],0.2096362026861578
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23561,264,0.97 [0.87-1.09],0.6515441057061668
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23721,698,1.00 [0.93-1.07],0.8983106389532545
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24064,41,1.20 [0.89-1.62],0.228988428304206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22697,53,0.93 [0.72-1.19],0.5476293365192684
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23334,37,1.10 [0.81-1.50],0.5507613980764032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23838,196,1.12 [0.98-1.28],0.0904271570274641
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22909,265,1.13 [1.00-1.26],0.0458281370726516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22678,34,1.17 [0.84-1.62],0.3517265938613049
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23999,64,1.04 [0.83-1.31],0.750028894457121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23140,117,1.16 [0.97-1.38],0.1036510052359506
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23902,133,0.87 [0.75-1.02],0.0818771282844616
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23666,24,0.82 [0.57-1.19],0.3058033600657795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22690,46,0.99 [0.76-1.30],0.9697271126341004
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23622,978,1.03 [0.98-1.10],0.2558610005784815
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22937,293,1.18 [1.05-1.31],0.004513229676133
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22682,38,1.26 [0.92-1.72],0.1491900573336592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24003,234,0.95 [0.84-1.07],0.4037954145439988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23697,55,0.90 [0.71-1.14],0.3848383744609766
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23960,191,0.92 [0.81-1.05],0.2069420988547146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24049,149,0.96 [0.83-1.11],0.574238237238784
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22750,106,1.10 [0.92-1.32],0.3119275872969664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22811,167,1.07 [0.92-1.23],0.382070609817969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24044,144,0.96 [0.82-1.11],0.5685828231217493
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22760,116,1.00 [0.84-1.19],0.9995778171531068
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24043,108,1.04 [0.88-1.25],0.6287268956609326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21091,115,1.02 [0.86-1.21],0.8253095892920326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22441,4070,1.00 [0.97-1.03],0.8491453938660505
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21247,2876,0.99 [0.96-1.02],0.5802715443698911
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21062,86,1.01 [0.83-1.24],0.8858002052593461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21570,139,1.07 [0.91-1.25],0.432816464445385
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21572,141,1.14 [0.97-1.33],0.1181664212708425
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23872,105,0.91 [0.76-1.09],0.3026345545975283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21474,43,0.90 [0.69-1.19],0.4734467296498658
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19041,670,0.98 [0.91-1.05],0.5469576326935327
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24021,114,0.91 [0.77-1.08],0.2916162825128195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21680,249,1.03 [0.92-1.16],0.6027736999653586
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21020,5462,1.01 [0.98-1.03],0.4523918115315152
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22847,97,0.93 [0.77-1.11],0.4028063765663012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21078,102,0.89 [0.75-1.06],0.1997289561433103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21522,546,1.05 [0.97-1.14],0.23067843675996
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23278,1847,1.02 [0.98-1.07],0.3469373084163446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21179,203,1.13 [0.99-1.29],0.0669414521110965
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21236,260,1.13 [1.00-1.27],0.0447227849979285
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21108,132,1.12 [0.95-1.32],0.1657830218993786
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23598,32,0.98 [0.71-1.36],0.9110574747317652
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19507,1136,1.01 [0.96-1.07],0.7263949994057478
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18714,343,1.01 [0.91-1.11],0.888663013348364
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24027,333,1.02 [0.92-1.12],0.7431632456664654
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18439,68,0.92 [0.74-1.14],0.4339125650687723
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18679,308,0.90 [0.81-1.00],0.0398319717359668
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21264,288,1.00 [0.90-1.11],0.9854115548618072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19038,667,1.02 [0.95-1.09],0.6766280049719542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21455,24,0.91 [0.63-1.32],0.6305993588577581
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21928,497,1.05 [0.97-1.14],0.2427416457817074
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21684,253,1.01 [0.90-1.14],0.8067762300388829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18990,619,1.00 [0.93-1.08],0.9159556324203092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21043,67,1.30 [1.02-1.64],0.0305999640430935
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21031,55,0.89 [0.70-1.14],0.3516478656246249
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22803,53,1.06 [0.82-1.36],0.6661097267902254
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23783,1033,0.99 [0.93-1.04],0.6250796956369702
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23331,581,0.98 [0.91-1.05],0.544909116723336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23969,307,1.07 [0.96-1.19],0.2177518174975218
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19925,1554,0.98 [0.94-1.03],0.4284452079147087
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18439,68,0.98 [0.78-1.23],0.8661786727666534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21045,69,1.05 [0.83-1.31],0.6972145237599296
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18396,25,0.83 [0.58-1.19],0.3094630920573913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18474,103,0.98 [0.82-1.17],0.7912742062947419
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22959,209,0.99 [0.87-1.13],0.9187493815204816
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22974,224,1.01 [0.89-1.14],0.8472804294496072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24039,74,0.96 [0.78-1.18],0.7042116766350226
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22820,1389,1.04 [0.99-1.09],0.1690095101541484
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21083,107,0.83 [0.70-0.98],0.0285183251672099
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18483,112,0.83 [0.70-0.98],0.0311507815882955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21989,558,0.98 [0.91-1.06],0.6783220125346602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20174,1803,1.00 [0.96-1.04],0.9570436577874843
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23617,51,1.02 [0.79-1.33],0.8611741986600505
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24051,68,0.93 [0.75-1.15],0.4836100095851118
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21046,70,1.09 [0.87-1.36],0.4708375556933327
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21949,973,1.02 [0.96-1.08],0.5653825576955955
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21036,60,0.95 [0.75-1.19],0.6401798317353681
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19368,997,1.04 [0.98-1.11],0.1611651005153303
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22845,95,1.01 [0.84-1.23],0.8792405207078408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21035,59,1.14 [0.89-1.47],0.2945164436083223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21531,100,1.02 [0.85-1.23],0.8252247126814272
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21324,348,0.97 [0.88-1.07],0.5040087634378441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23755,189,1.10 [0.96-1.26],0.1785970964181534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21854,423,1.05 [0.96-1.14],0.3340642186557173
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23978,292,1.09 [0.98-1.21],0.1268924710763356
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24058,34,1.04 [0.76-1.44],0.7925246925799012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21162,186,1.04 [0.90-1.18],0.6161747590561738
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19291,545,1.07 [0.98-1.15],0.1179057215206502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21416,440,0.96 [0.88-1.05],0.3599905239367111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21127,151,1.16 [1.00-1.36],0.0575056983268194
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18405,34,0.76 [0.56-1.03],0.0771311864339565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19936,1565,1.04 [0.99-1.08],0.1433592821029591
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18769,398,0.93 [0.85-1.02],0.1331287076350835
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23644,78,1.13 [0.92-1.40],0.2517233572339294
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24009,44,0.91 [0.70-1.19],0.496639703937543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22676,26,1.09 [0.76-1.57],0.6342393671837672
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18441,70,0.91 [0.73-1.13],0.3928410455167261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21511,80,1.08 [0.87-1.33],0.4873642530514338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18681,310,1.06 [0.96-1.18],0.2612408180223169
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21216,240,0.94 [0.84-1.06],0.3309196469913261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21623,192,1.11 [0.97-1.27],0.1291060634686613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21522,91,0.96 [0.79-1.16],0.6528105544259812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20341,44,1.14 [0.85-1.51],0.3814055811907976
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24061,37,0.99 [0.73-1.34],0.9476701852616428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21502,526,0.98 [0.91-1.06],0.6271422831240513
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23643,77,1.00 [0.82-1.24],0.9627299761826876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23125,2149,1.02 [0.98-1.06],0.4591885229134455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21076,100,1.03 [0.85-1.23],0.7884072155055514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21749,318,1.04 [0.93-1.15],0.4966011994592065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22828,164,1.09 [0.95-1.26],0.2293961329232989
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21563,132,1.06 [0.90-1.24],0.5089952366076402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22377,946,1.00 [0.94-1.06],0.9008941208775988
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22051,620,0.96 [0.89-1.03],0.2798443639846982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21015,39,1.03 [0.76-1.40],0.8332342332441839
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23709,143,1.12 [0.95-1.31],0.1688955895995801
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21115,139,1.08 [0.92-1.26],0.3614482392511751
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21029,53,0.90 [0.70-1.15],0.3870259175927927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18404,33,0.89 [0.65-1.22],0.4785592616394203
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,23615,749,1.05 [0.99-1.13],0.1273147243127496
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9771,63,1.07 [0.84-1.36],0.5786062008327292
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13003,72,0.87 [0.71-1.08],0.2026283881786044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23817,272,0.96 [0.86-1.08],0.5023352843086171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23599,54,0.82 [0.64-1.04],0.0980871232955185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23428,562,1.03 [0.95-1.11],0.4313140504484695
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23915,19,0.59 [0.41-0.86],0.0053691752837134
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23921,160,0.97 [0.84-1.12],0.716066880674059
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,22124,136,0.97 [0.83-1.13],0.6945632524432273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dialysis,22908,42,1.34 [0.99-1.81],0.0540958996956054
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10406,987,1.02 [0.96-1.09],0.4448917159397515
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,13105,174,0.93 [0.81-1.06],0.2632858813905899
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,9822,114,1.03 [0.86-1.23],0.7530883740589556
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10039,331,0.88 [0.79-0.97],0.0096402040303724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10081,373,1.02 [0.92-1.12],0.7439173748767689
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20282,3695,1.01 [0.98-1.04],0.4040917069366921
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23954,58,1.03 [0.81-1.30],0.8330790317427179
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydrocele,9488,69,1.11 [0.89-1.40],0.3564869802878914
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22790,195,1.03 [0.90-1.18],0.646640333107044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10075,656,1.04 [0.97-1.12],0.2663368431506329
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12983,207,0.93 [0.82-1.05],0.2460294643607619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9512,93,0.93 [0.77-1.13],0.4759928720632892
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,13003,106,0.75 [0.64-0.89],0.0009935666357216
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,9966,258,0.97 [0.86-1.08],0.5522333394945098
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22042,54,1.09 [0.84-1.41],0.5095346491214033
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10931,1223,1.00 [0.95-1.06],0.8862679367851889
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9466,47,0.95 [0.73-1.25],0.7264625821658212
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9795,87,1.19 [0.97-1.46],0.1024700153860124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24065,35,1.22 [0.88-1.70],0.2232177635159346
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24070,42,0.97 [0.73-1.28],0.8172441369288267
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23309,1321,1.02 [0.97-1.07],0.4552328862599697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22399,411,0.98 [0.89-1.07],0.6273357718726804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12986,55,0.99 [0.77-1.26],0.9290543634772894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24028,267,1.04 [0.93-1.17],0.4489222497984761
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9556,137,1.01 [0.86-1.18],0.9332298472252438
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9523,104,0.92 [0.77-1.09],0.3250303143552554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9481,62,1.01 [0.80-1.28],0.9024241676532462
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24041,50,0.98 [0.76-1.27],0.9079447021777788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22963,975,1.02 [0.96-1.08],0.4528781321856785
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12883,107,1.08 [0.90-1.30],0.3973424775008435
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9777,69,1.17 [0.93-1.47],0.1812298401624091
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9912,204,1.04 [0.92-1.19],0.524935708053068
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9762,54,1.32 [1.01-1.72],0.0411765225494623
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9803,95,1.11 [0.92-1.35],0.2833314231532017
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22820,225,1.04 [0.92-1.17],0.5782102565958047
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23853,92,1.12 [0.92-1.36],0.2598213147254978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9858,150,1.09 [0.93-1.27],0.2827077820939945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9776,68,0.98 [0.78-1.22],0.8522372843750997
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10074,366,1.01 [0.92-1.12],0.7723837479082876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9765,57,0.92 [0.73-1.17],0.5043403210895796
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10031,323,1.05 [0.95-1.16],0.373044856253461
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23936,40,1.03 [0.77-1.38],0.8323566678334833
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9514,95,1.14 [0.94-1.38],0.1850830144419861
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23912,1317,1.04 [0.99-1.09],0.1498768353845157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22719,124,1.05 [0.89-1.24],0.5775820980673834
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22925,59,0.90 [0.71-1.14],0.3870536448985994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23606,61,0.98 [0.78-1.24],0.8697743429446554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,22133,145,1.11 [0.95-1.30],0.1934831705716171
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23875,330,0.94 [0.85-1.04],0.2457304686214723
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,9793,85,1.16 [0.94-1.42],0.1668767478107166
